Prognostic impact of KRAS mutation subtypes in 677 patients with metastatic lung adenocarcinomas

BACKGROUND: We previously demonstrated that patients with metastatic KRAS mutant lung cancers have a shorter survival compared to patients with KRAS wild type cancers. Recent reports have suggested different clinical outcomes and distinct activated signaling pathways depending on KRAS mutation subty...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Oncol
Main Authors: Yu, Helena A., Sima, Camelia S., Shen, Ronglai, Kass, Samantha, Gainor, Justin, Shaw, Alice, Hames, Megan, Iams, Wade, Aston, Jonathan, Lovly, Christine M., Horn, Leora, Lydon, Christine, Oxnard, Geoffrey R., Kris, Mark G., Ladanyi, Marc, Riely, Gregory J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4479120/
https://ncbi.nlm.nih.gov/pubmed/25415430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000432
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados